IGMS: IGM Biosciences, Inc. Stock

by  •  • Comments Off on IGMS: IGM Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 40.92
Enterprise Value ($M) 14.43
Book Value ($M) 48.17
Book Value / Share 1.40
Price / Book 0.85
NCAV ($M) -23.92
NCAV / Share -0.70
Price / NCAV -1.71

Profitability (mra)
Return on Invested Capital (ROIC) -2.10
Return on Assets (ROA) -0.52
Return on Equity (ROE) -1.21

Liquidity (mrq)
Quick Ratio 5.14
Current Ratio 5.14

Balance Sheet (mrq) ($M)
Current Assets 193.62
Assets 265.71
Liabilities 217.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.68
Operating Income -194.22
Net Income -195.79
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -153.00
Cash from Investing 64.16
Cash from Financing 2.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/ 10.50
11-12 13G/A Fmr Llc 2.42 -51.75
08-02 13G/A Invus Global Management, LLC 9.90
2024-03-28 13D/A Baker Bros. Advisors Lp 12.40 10.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K Annual Report on Form 10-K for the fiscal year ended December 31, 2024
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 9,036 69,978 12.91
2025-04-16 15,521 110,431 14.05
2025-04-15 66,884 272,232 24.57
2025-04-14 35,092 159,472 22.01

(click for more detail)

Similar Companies
IDXX – IDEXX Laboratories, Inc. IDYA – IDEAYA Biosciences, Inc.
IFRX – InflaRx N.V. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc.


Financial data and stock pages provided by
Fintel.io